Yu Shengjian, Guo Zeying, Qiu Zijian, Wang Liejiong, Chen Xiuxia, Xuan Feng
Department of Radiation Oncology, Zhuji Affiliated Hospital of Wenzhou Medical University, Shaoxing, China.
Department of Medical Oncology, Zhuji Affiliated Hospital of Wenzhou Medical University, Shaoxing, China.
Sci Rep. 2024 Dec 30;14(1):31787. doi: 10.1038/s41598-024-82897-4.
Testicular cancer predominantly affects adolescents and young adults (AYAs) aged 15-39 years. This study analyzed the global, regional, and national burden of testicular cancer among AYAs (1990 to 2021). Data from the Global Burden of Disease study was used to calculate age-standardized rates of incidence (ASIR), prevalence (ASPR), and disability-adjusted life years (ASDR). Trends were assessed using the Joinpoint regression and Bayesian age-period-cohort models, with projections up to 2035. Results showed the global ASIR of 4.05 (95% CI: 3.80-4.35), ASPR of 31.05 (95% CI: 28.88-33.68), and ASDR of 24.82 (95% CI: 22.99-26.91) per 100,000 in 2021, respectively. From 1990 to 2021, ASIR and ASPR increased, while ASDR remained relatively stable. Significant geographical disparities were observed, with Europe and Latin America showing higher burdens compared to Asia and Africa. The 25-29 age group had the highest age-specific rate of incidence (5.58; 95% UI: 5.25-5.97) and disability-adjusted life years (34.09; 95% UI: 31.55-37.11) per 100,000, while the 30-34 age group had the highest age-specific prevalence rate (43.12; 95% UI: 40.51-46.56) per 100,000 in 2021. By 2035, the global numbers of incidence and prevalence cases were projected to increase, with DALYs and age-standardized rates declining. These findings are crucial for informing global strategies in testicular cancer prevention.
睾丸癌主要影响15至39岁的青少年和青年(AYAs)。本研究分析了1990年至2021年间AYAs中睾丸癌的全球、区域和国家负担。全球疾病负担研究的数据用于计算年龄标准化发病率(ASIR)、患病率(ASPR)和伤残调整生命年(ASDR)。使用Joinpoint回归和贝叶斯年龄-时期-队列模型评估趋势,并预测至2035年。结果显示,2021年全球ASIR为每10万人4.05(95%CI:3.80-4.35),ASPR为31.05(95%CI:28.88-33.68),ASDR为24.82(95%CI:22.99-26.91)。1990年至2021年,ASIR和ASPR上升,而ASDR相对稳定。观察到显著的地理差异,欧洲和拉丁美洲的负担高于亚洲和非洲。2021年,25至29岁年龄组的年龄别发病率最高(每1万人5.58;95%UI:5.25-5.97)和伤残调整生命年最高(每1万人34.09;95%UI:31.55-37.11),而30至34岁年龄组的年龄别患病率最高(每1万人43.12;95%UI:40.51-46.56)。到·2035年,预计全球发病率和患病率病例数将增加,而伤残调整生命年和年龄标准化率将下降。这些发现对于为睾丸癌预防的全球战略提供信息至关重要。